Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
Latest reported PHAT revenue for 2026-06-30 was $132.6M. Net income was -$48.0M. PHAT currently screens at market cap $622.7M.
Use this PHAT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PHAT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PHAT SEC filings page. Lician reads the product cache first so this HTML stays unique to Phathom Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full PHAT income, balance, and cash tables.